JP3628196B2 - Antioxidant and composition containing the same - Google Patents

Antioxidant and composition containing the same Download PDF

Info

Publication number
JP3628196B2
JP3628196B2 JP00250999A JP250999A JP3628196B2 JP 3628196 B2 JP3628196 B2 JP 3628196B2 JP 00250999 A JP00250999 A JP 00250999A JP 250999 A JP250999 A JP 250999A JP 3628196 B2 JP3628196 B2 JP 3628196B2
Authority
JP
Japan
Prior art keywords
antioxidant
extract
chamaedryoides
extraction
urtica
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP00250999A
Other languages
Japanese (ja)
Other versions
JP2000198713A (en
Inventor
敏 吉谷
文伸 吉見
誉 多葉田
博行 原口
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Chemicals Inc
Original Assignee
Mitsui Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Chemicals Inc filed Critical Mitsui Chemicals Inc
Priority to JP00250999A priority Critical patent/JP3628196B2/en
Publication of JP2000198713A publication Critical patent/JP2000198713A/en
Application granted granted Critical
Publication of JP3628196B2 publication Critical patent/JP3628196B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)

Description

【0001】
【発明の属する技術分野】
本発明は、抗酸化剤及び該抗酸化剤を含有する組成物に関するものである。更に本発明は、該抗酸化剤を含有する医薬品、医薬部外品、化粧品などの分野に利用可能な皮膚外用剤に関するものである。
【0002】
【従来の技術】
近年、生体内で生成される活性酸素が、不飽和脂肪酸と反応して過酸化脂質を生じ、人体に悪影響を及ぼすことが明らかになってきている。例えば、活性酸素は、虚血障害や放射線障害、過酸化脂質やその酸化分解物は、核酸や蛋白に作用し、動脈硬化、高血圧症、それらにより発症するによる血管障害、肝機能障害、網膜症や白内障などを引き起こす。特に皮膚では、紫外線などの環境因子の刺激を直接受けるため、活性酸素が生成しやすく、活性酸素濃度の上昇、過酸化脂質の生成等のシミ・ソバカス等の異常な色素沈着、炎症、浮腫、壊死、皺、老化等その影響が顕著である。
【0003】
又、化粧品、医薬品、飲食品等においては、油脂類を含有するものが多く、保存中や使用時に活性酸素と反応して過酸化脂質を生成し、これによる品質低下や栄養の低下・人体への毒性の発現が大きな問題になっている。
【0004】
このために、従来より生体内過酸化脂質異常を改善するために、抗酸化作用を有する薬剤の探索研究が、広く行われている。代表的なものでは、天然物抗酸化剤として、脂溶性のトコフェロール(ビタミンE)や、水溶性のアスコルビン酸(ビタミンC)があり、合成抗酸化剤としてBHT(3,5−tert−butyl−4−hydroxytolen)やBHA(2,(3)−tert−butyl−hydroxyanysol)等が挙げられるが、その効果は満足できるものではなかった。
【0005】
これに対し、生体内過酸化脂質異常を改善するために、抗酸化作用の高い物質を得ようという試みが数多くなされており、種々の生薬抽出物が開示されている(例えば、特開平5−246877号、特開平8−92053号、特開平8−301745号等)。
【0006】
【発明が解決しようとする課題】
しかし、上記生薬抽出物は、トコフェロールやアスコルビン酸等に比べれば、ある程度高い抗酸化作用を持つが、その作用は満足すべきものではない。又、合成抗酸化剤のBHT、BHAには、発癌性の疑いが持たれている等の問題がある。従って、これらの抗酸化剤の他に同様の過酸化脂質生成の抑制手段を有し、かつ安全性の高い物質が望まれている。
【0007】
【課題を解決するための手段】
本発明者らは、このような状況を鑑み、従来技術の問題点を改良せんとして鋭意研究を重ねた結果、驚くべきことにイラクサ科イラクサ属の植物であるウルティカ・カマドロイド(Urtica chamaedryoides)の抽出物が、強いフリーラジカル消去作用、抗酸化作用を有することを見出した。
【0008】
すなわち、本発明は、イラクサ科イラクサ属の植物であるウルティカ・カマドロイド(Urtica chamaedryoides)の抽出物を含有することを特徴とする抗酸化剤及びこの抗酸化剤を含有する化粧品、食品、医薬品等の組成物を提供するものである。
【0009】
【発明の実施の形態】
以下、本発明の実施の形態を詳述する。
発明に用いるウルティカ・カマドロイド(Urtica chamaedryoides)とは、メキシコ原産のイラクサ科イラクサ属に属する植物である。
【0010】
本発明で使用するウルティカ・カマドロイド(Urtica chamaedryoides)の抽出物とは、当該植物の葉、茎、花、種子、果実、樹皮、根茎、根等の植物体の一部または全部から抽出して得られるものである。好ましくは、種子もしくは茎の一方、又は両方の混合物から抽出して得られるものがよい。又、一般的には乾燥あるいは生植物をそのままあるいは裁断して使用する。使用する抽出溶媒は、当乾燥又は生植物の乾物換算当たり5〜50部に対し下記抽出溶媒100部が用いられる。
【0011】
抽出溶媒としては、一般的には水、低級1価アルコール類(メタノール、エタノール、1―プロパノール、2―プロパノール、1―ブタノール、2―ブタノール等)、液状多価アルコール(1,3―ブチレングリコール、プロピレングリコール等)、低級アルキルエステル(酢酸エチル等)、炭化水素(ベンゼン、ヘキサン、ペンタン等)、ケトン類(アセトン、メチルエチルケトン等)、エーテル類(ジエチルエーテル、テトラヒドロフラン、ジプロピルエーテル)、アセトニトリル等が挙げられる。これらの溶媒は単独で用いても2種以上を混合して用いても良い。好ましくは、水もしくは水溶性溶媒(水との任意の割合で混合可能な溶媒。例えば、エタノール、メタノール、プロピレングリコール等)のうち1種又は2種以上の溶媒を用いるのがよい。
【0012】
抽出方法は特に限定されないが、常温又は加熱下で行われ、その方式としては通常抽出、ソックスレー抽出等がある。抽出時間に制限はないが一般的には1時間〜1週間が好ましい。
【0013】
当該抽出液はそのまま使用しても良いが、各種処理を施して使用することもできる。例えばこれらを常圧あるいは減圧下で濃縮した濃縮液、又はさらに該濃縮液中の溶媒を蒸発乾固させた固形物、また濃縮液から晶析後濾別乾燥した固形物、又は濃縮液を凍結乾燥した固形物等が挙げられる。
【0014】
本発明に係るウルティカ・カマドロイド(Urtica chamaedryoides)の抽出物の抗酸化剤としての乾物換算当たりの使用量(配合量)は、特に限定されないが、総量を基準として0.001〜20.0重量%(以下 wt%という)、特に0.01〜10wt%が望ましい。
【0015】
本発明の抗酸化剤を含有する組成物は、上記抗酸化剤を配合することを特徴とし、その用途は任意であるが化粧品、食品、医薬品、医薬部外品、トイレタリー用品等に広く用いることができる。
【0016】
本発明が適用される化粧品としては、剤形は特に限定されず、例えば、化粧水、乳液、クリーム、ファンデーション、パック、口紅、洗顔料、シャンプー、リンス、ヘアトニック等を挙げることができる。これらの化粧品には、化粧品に一般的に用いられる各種成分、すなわち水性成分、油性成分、粉末成分、アルコール類、エステル類、界面活性剤、保湿剤、美白成分、紫外線吸収剤、増粘剤、色剤、香料、抗酸化剤、pH調整剤、キレート剤、防腐剤等の成分を配合することができる。
【0017】
本発明が適用される食品は、特に限定されず、例えば一般食品として各々の食品原料に抽出物の所要量を加え、通常の製造法により加工製造することにより得ることができる。
【0018】
本発明が適用される医薬品、医薬部外品としては、剤形は特に限定されず、例えば錠剤、顆粒剤、カプセル剤、水薬等の内服剤、軟膏、パップ剤、クリーム、水剤などの外用剤、無菌溶液剤、懸濁液剤等の注射剤、浴用剤等が挙げられる。これらの医薬品は、生理的に認められるベヒクル、担体、賦形剤、結合剤、安定剤、香味剤等と共に要求される単位用量形態をとりうる。例えば、錠剤、カプセル剤のための組成物は、トラガント、アラビアゴム、ゼラチン等の結合剤、微晶性セルロース等の賦形剤、ゼラチン化澱粉、アルギン酸等の膨化剤、ステアリン酸マグネシウム等の潤滑剤、ショ糖、乳糖、サッカリンのような甘味剤、ペパーミント、アカモノ油、チェリーのような香味剤等を共に混和し、通常の方法によって処方することができる。また、注射剤のための無菌組成物は、注射用水のようなベヒクル中の活性物質、ゴマ油、ヤシ油、落花生油、綿実油のような天然産出植物油、またはエチルオレートのような合成脂肪ベヒクルを溶解又は懸濁させる通常の方法によって処方することができる。外用剤としては基剤としてワセリン、パラフィン、油脂類、ラノリン、マクロゴール等を用い、通常の方法によって軟膏剤、クリーム剤とする。
【0019】
本発明の皮膚外用剤とは、外用可能なあらゆる剤形を意味し、例えば、化粧水、乳液、クリーム、ファンデーション、パック、エッセンス、口紅、洗顔料、ゲル剤、エアゾル剤、軟膏、パップ剤、ペースト剤、プラスター剤浴用剤、洗浄剤等の皮膚に適用されるものや、シャンプー、リンス、トリートメント、ヘアトニック等の毛髪に適用されるものを挙げることができる。また、本発明の皮膚外用剤は、医薬用、医薬部外用、化粧用のいずれにも用いることができる。
【0020】
本発明の皮膚外用剤には、通常の皮膚外用剤に用いられる成分である水性成分、油性成分、粉末成分、ロウ類、脂肪酸類、アルコール類、エステル類、界面活性剤、保湿剤、美白成分、紫外線吸収剤、増粘剤、色剤、香料、抗酸化剤、pH調整剤、キレート剤、防腐剤等を本発明の目的を達成する範囲内で適宜配合することができる。
【0021】
【実施例】
以下、実施例に基づいて本発明を詳細に説明する。なお、本発明はこれらに限定されるものではない。
【0022】
[抽出例1](ウルティカ・カマドロイド(Urtica chamaedryoides)抽出物Iの製造)
乾燥したウルティカ・カマドロイド(Urtica chamaedryoides)100gを1Lのメタノールで室温にて24時間抽出、さらにその後2回同様に抽出を行った後、抽出液を併せて濃縮乾固し、粉状固形物10.6gを得た。
【0023】
[抽出例2](ウルティカ・カマドロイド(Urtica chamaedryoides)抽出物IIの製造)
乾燥したウルティカ・カマドロイド(Urtica chamaedryoides)100gを水/エタノール(1:1、容量比)溶媒1L中に入れ、室温で24時間攪拌しながら抽出を行った後濾過し、その濾液を濃縮乾固し、粉状固形物8.3gを得た。
【0024】
[抽出例3](ウルティカ・カマドロイド(Urtica chamaedryoides)抽出物IIIの製造)
乾燥したウルティカ・カマドロイド(Urtica chamaedryoides)100gを1Lの1,3―ブチレングリコールと水との混合液(1:1)で室温にて10日間抽出後濾過し、その濾液を濃縮乾固し、粉状固形物10gを得た。
【0025】
[試験例1] DPPHラジカル消去試験
上記抽出物I〜IIIの抗酸化能を調べるために、以下のDPPHラジカル消去試験方法にて各抽出物を評価した。尚、比較のために、既にラジカル除去作用のあることで知られているローズマリー(学名:Rosmarinus officinalis)の50%エタノール抽出物についても同様の評価を行い、検体100ug/ml、10ug/ml、1ug/mlにおけるラジカル除去率(%)を求めた。
具体的な試験法は以下のとおりである。中性ラジカルであるDiphenyl-p-picrylhydradil(DPPH)のエタノール液を用いて、上記抽出物の脂質のラジカル連鎖反応の阻止効果を検討した。250mM 酢酸緩衝液(pH 5.5) 800ulにエタノール 800ul、検体 20ulを混合し、30℃ 5分間プレインキュベートする。この液に、250uM DPPH/エタノール溶液を400ul添加混合し30℃ 30分間放置後、517nmの吸光度を測定し、その後300ug/ml BHT(3,5-tert-butyl-4-hydroxytolen)20ulを添加し、完全にDPPHラジカルを除去した場合の吸光度を測定する。この差から、ラジカル除去率を求める。結果を第1表(表1)に示す。抽出例1,2,3のウルティカ・カマドロイド(Urtica chamaedryoides)抽出物は、ローズマリー抽出物に匹敵するDPPHラジカル消去作用を有することがわかった。
【0026】
【表1】

Figure 0003628196
【0027】
[実施例1](クリーム)
下記記載の配合量においてB成分をA成分に混合し、均一に加熱溶解して温度を80℃にした。次いでC成分を注入撹拌混合した後、撹拌しながら30℃まで冷却しクリームを得た。
Figure 0003628196
【0028】
[比較例1](クリーム)
実施例1において成分(B)ウルティカ・カマドロイド(Ultica chamaedryoides)抽出物を除いた以外はすべて実施例1と同様にして調製し、前述した各試験に使用した。
【0029】
[実施例2](二相型ローション)
下記記載の配合量においてA成分を室温にて均一に混合溶解し、B成分をゆっくり撹拌添加し二相型ローションを得た。
Figure 0003628196
【0030】
[比較例2](二相型ローション)
実施例2において成分(B)ウルティカ・カマドロイド(Urtica chamaedryoides)抽出物を除いた以外はすべて実施例2と同様にして調製し、前述した各試験に使用した。
【0031】
[試験例2] 有用性評価試験
実施例1、2及び比較例1、2で調製された組成物の有用性は、以下に示す試験方法により試験した。
則ち、健康な女性(25〜40才)80名を20名ずつに4群に分け、それぞれ実施例1、2及び比較例1、2の試料を1日2回ずつ塗布し、塗布開始後3ヶ月後の老化防止効果(肌荒れ防止、皮膚の艶・張り)についてアンケート調査を行って評価した。アンケートの評価基準は、有効なものを「優」、やや有効なものを「良」、わずかに有効なものを「可」、無効なものを「不可」として、比較例と比較して評価を行った。
第2表(表2)に示すごとく、比較例1、2に比べ実施例1、2では良好な結果が得られた。
【0032】
【表2】
Figure 0003628196
【0033】
[実施例3](油性軟膏)
下記記載の配合量において各成分を混合し、80℃まで加温し徐々に冷却し油性軟膏を得た。
Figure 0003628196
【0034】
[試験例3]
実施例3において調製された油性軟膏を試験例1の抗酸化効果の評価試験法に示す方法と同様の方法に準じ抗酸化試験を行った。その結果、該油性軟膏は(B)成分を配合しない以外全ての成分を含む油性軟膏と比べて、DPPHラジカル消去作用に優れていた。
【0035】
【発明の効果】
以上記載の如く、本発明の抗酸化剤を含む化粧品、医薬品、医薬部外品、食品等の組成物は、生体内に生成した活性酸素や過酸化脂質によって引き起こされる障害を抑制する効果がある。従って、健康上、美容上の障害についての治療に有効であり、さらに飲食品の安定化・保存性の向上にも有用である。[0001]
BACKGROUND OF THE INVENTION
The present invention relates to an antioxidant and a composition containing the antioxidant. Furthermore, this invention relates to the skin external preparation which can be utilized in field | areas, such as a pharmaceutical containing this antioxidant, a quasi-drug, and cosmetics.
[0002]
[Prior art]
In recent years, it has been clarified that active oxygen generated in a living body reacts with an unsaturated fatty acid to produce lipid peroxide and adversely affect the human body. For example, active oxygen acts on ischemic damage and radiation damage, lipid peroxide and its oxidative degradation products act on nucleic acids and proteins, causing arteriosclerosis, hypertension, vascular disorders caused by them, liver dysfunction, retinopathy Cause cataracts. Especially in the skin, since it is directly stimulated by environmental factors such as ultraviolet rays, it is easy to generate active oxygen, abnormal active pigmentation such as spots and freckles such as increased active oxygen concentration, lipid peroxide generation, inflammation, edema, The effects such as necrosis, wrinkles, and aging are remarkable.
[0003]
In addition, cosmetics, pharmaceuticals, foods and drinks, etc., often contain oils and fats, react with active oxygen during storage and use to produce lipid peroxides, resulting in reduced quality, reduced nutrition, and the human body. The emergence of toxicity has become a major problem.
[0004]
For this reason, in order to improve in vivo lipid peroxide abnormalities, research for searching for drugs having an antioxidant action has been widely performed. Typical examples include fat-soluble tocopherol (vitamin E) and water-soluble ascorbic acid (vitamin C) as natural product antioxidants, and BHT (3,5-tert-butyl-) as a synthetic antioxidant. 4-hydroxytolen) and BHA (2, (3) -tert-butyl-hydroxysol) are exemplified, but the effect is not satisfactory.
[0005]
On the other hand, many attempts have been made to obtain substances having a high antioxidant effect in order to improve in vivo lipid peroxide abnormalities, and various herbal medicine extracts have been disclosed (for example, Japanese Patent Laid-Open No. Hei 5- No. 246877, JP-A-8-92053, JP-A-8-301745, etc.).
[0006]
[Problems to be solved by the invention]
However, the herbal extract has a somewhat higher antioxidant effect than tocopherol and ascorbic acid, but the effect is not satisfactory. In addition, the synthetic antioxidants BHT and BHA have problems such as suspected carcinogenicity. Therefore, in addition to these antioxidants, there is a demand for highly safe substances that have the same means for inhibiting lipid peroxide production.
[0007]
[Means for Solving the Problems]
In view of such circumstances, the present inventors have conducted extensive research to improve the problems of the prior art, and as a result, surprisingly, the extraction of Urtica chamaedryoides, a plant belonging to the genus Nettle, is a genus of nettle. It was found that the product has strong free radical scavenging action and antioxidant action.
[0008]
That is, the present invention includes an antioxidant characterized by containing an extract of Urtica chamaedryoides, which is a plant belonging to the family Nettle, and cosmetics, foods, pharmaceuticals and the like containing the antioxidant. A composition is provided.
[0009]
DETAILED DESCRIPTION OF THE INVENTION
Hereinafter, embodiments of the present invention will be described in detail.
Urtica chamaedryoides used in the invention are plants belonging to the genus Nettle, which is native to Mexico.
[0010]
The extract of Ultica chamaedryoides used in the present invention is obtained by extracting from a part or all of a plant body such as leaves, stems, flowers, seeds, fruits, bark, rhizomes and roots of the plant. It is what Preferably, one obtained by extraction from one or both of seeds and stems is good. In general, dried or live plants are used as they are or after being cut. As the extraction solvent to be used, 100 parts of the following extraction solvent is used for 5 to 50 parts per dry matter or dry matter equivalent of the live plant.
[0011]
The extraction solvent is generally water, lower monohydric alcohols (methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, etc.), liquid polyhydric alcohol (1,3-butylene glycol). , Propylene glycol, etc.), lower alkyl esters (ethyl acetate, etc.), hydrocarbons (benzene, hexane, pentane, etc.), ketones (acetone, methyl ethyl ketone, etc.), ethers (diethyl ether, tetrahydrofuran, dipropyl ether), acetonitrile, etc. Is mentioned. These solvents may be used alone or in combination of two or more. Preferably, one or two or more solvents among water or a water-soluble solvent (solvents that can be mixed with water in an arbitrary ratio. For example, ethanol, methanol, propylene glycol, etc.) may be used.
[0012]
The extraction method is not particularly limited, and the extraction is performed at room temperature or under heating. Examples of the method include normal extraction and Soxhlet extraction. Although there is no restriction | limiting in extraction time, Generally 1 hour-1 week are preferable.
[0013]
The extract may be used as it is, but can also be used after various treatments. For example, a concentrated solution obtained by concentrating these under normal pressure or reduced pressure, or a solid obtained by evaporating the solvent in the concentrated solution to dryness, a solid obtained by crystallization from the concentrated solution and then filtered and dried, or a concentrated solution are frozen. Examples include dried solids.
[0014]
Although the usage-amount (blending amount) per dry matter conversion as an antioxidant of the extract of Ultica chamaedryoides which concerns on this invention is not specifically limited, 0.001-20.0 weight% on the basis of a total amount (Hereinafter referred to as “wt%”), particularly 0.01 to 10 wt%.
[0015]
The composition containing the antioxidant of the present invention is characterized by blending the above-mentioned antioxidant, and its use is arbitrary, but it can be widely used in cosmetics, foods, pharmaceuticals, quasi drugs, toiletries, etc. Can do.
[0016]
The cosmetic form to which the present invention is applied is not particularly limited, and examples thereof include skin lotion, emulsion, cream, foundation, pack, lipstick, face wash, shampoo, rinse, hair tonic and the like. These cosmetics include various components generally used in cosmetics, that is, aqueous components, oily components, powder components, alcohols, esters, surfactants, moisturizers, whitening components, ultraviolet absorbers, thickeners, Components such as a colorant, a fragrance, an antioxidant, a pH adjuster, a chelating agent, and an antiseptic can be blended.
[0017]
The food to which the present invention is applied is not particularly limited, and can be obtained, for example, by adding a required amount of an extract to each food raw material as a general food and processing and producing it by a normal production method.
[0018]
The pharmaceutical form and quasi-drug to which the present invention is applied are not particularly limited in dosage form. For example, tablets, granules, capsules, oral preparations such as liquid medicine, ointments, poultices, creams, liquid preparations, etc. Examples include external preparations, sterile solutions, suspensions and other injections, bath preparations and the like. These medicaments can take the required unit dosage forms together with physiologically recognized vehicles, carriers, excipients, binders, stabilizers, flavoring agents and the like. For example, compositions for tablets and capsules include binders such as tragacanth, gum arabic, and gelatin, excipients such as microcrystalline cellulose, gelatinizing starch, swelling agents such as alginic acid, and lubricants such as magnesium stearate. An agent, a sweetener such as sucrose, lactose, and saccharin, a flavoring agent such as peppermint, red mono oil, and cherry can be mixed together and formulated by an ordinary method. In addition, sterile compositions for injection dissolve active substances in vehicles such as water for injection, naturally produced vegetable oils such as sesame oil, coconut oil, peanut oil, cottonseed oil, or synthetic fat vehicles such as ethyl oleate Or it can be formulated by the usual method of suspending. As an external preparation, vaseline, paraffin, fats and oils, lanolin, macrogol and the like are used as a base, and an ointment and a cream are prepared by a usual method.
[0019]
The topical skin preparation of the present invention means any dosage form that can be applied externally, such as lotion, milky lotion, cream, foundation, pack, essence, lipstick, face wash, gel, aerosol, ointment, poultice, Examples include those applied to the skin such as paste agents, plaster bath agents, and cleaning agents, and those applied to hair such as shampoos, rinses, treatments, and hair tonics. Moreover, the external preparation for skin of the present invention can be used for any of pharmaceutical use, pharmacy use and cosmetic use.
[0020]
The skin external preparation of the present invention includes an aqueous component, an oily component, a powder component, a wax, a fatty acid, an alcohol, an ester, a surfactant, a moisturizing agent, and a whitening component, which are components used in normal skin external preparations. UV absorbers, thickeners, colorants, fragrances, antioxidants, pH adjusters, chelating agents, preservatives and the like can be appropriately blended within the scope of achieving the object of the present invention.
[0021]
【Example】
Hereinafter, the present invention will be described in detail based on examples. The present invention is not limited to these.
[0022]
[Extraction Example 1] (Production of Urtica chamaedryoides extract I)
Extract 100 g of dried Urtica chamaedryoides with 1 L of methanol at room temperature for 24 hours, and then perform extraction twice in the same manner, then concentrate the extract together and dry to dryness. 6 g was obtained.
[0023]
[Extraction Example 2] (Production of Urtica chamaedryoides extract II)
100 g of dried Urtica chamaedryoides in 1 L of water / ethanol (1: 1, volume ratio) solvent, extracted with stirring at room temperature for 24 hours, filtered, and the filtrate was concentrated to dryness 8.3 g of a powdery solid was obtained.
[0024]
[Extraction Example 3] (Production of Urtica chamaedryoides Extract III)
100 g of dried Urtica chamaedryoides is extracted with 1 L of a mixture of 1,3-butylene glycol and water (1: 1) at room temperature for 10 days, filtered, and the filtrate is concentrated to dryness and dried. 10 g of a solid was obtained.
[0025]
[Test Example 1] DPPH radical scavenging test In order to examine the antioxidant ability of the extracts I to III, each extract was evaluated by the following DPPH radical scavenging test method. For comparison, the same evaluation was performed for a 50% ethanol extract of rosemary (scientific name: Rosmarinus officinalis), which is already known to have a radical scavenging action, and specimens 100 ug / ml, 10 ug / ml, The radical removal rate (%) at 1 ug / ml was determined.
The specific test method is as follows. Using the ethanol solution of Diphenyl-p-picrylhydradil (DPPH), which is a neutral radical, the effect of inhibiting the lipid radical chain reaction of the above extract was examined. Add 800 ul of ethanol and 20 ul of specimen to 800 ul of 250 mM acetate buffer (pH 5.5), and preincubate at 30 ° C. for 5 minutes. To this solution, add 400 ul of 250 uM DPPH / ethanol solution, leave it at 30 ° C. for 30 minutes, measure the absorbance at 517 nm, and then add 20 ul of 300 ug / ml BHT (3,5-tert-butyl-4-hydroxytolen). The absorbance when the DPPH radical is completely removed is measured. From this difference, the radical removal rate is determined. The results are shown in Table 1 (Table 1). It was found that the Urtica chamaedryoides extract of Extraction Examples 1, 2, and 3 has a DPPH radical scavenging action comparable to that of rosemary extract.
[0026]
[Table 1]
Figure 0003628196
[0027]
[Example 1] (Cream)
In the blending amount described below, the B component was mixed with the A component, and uniformly heated and dissolved to a temperature of 80 ° C. Next, component C was injected and mixed with stirring, and then cooled to 30 ° C. with stirring to obtain a cream.
Figure 0003628196
[0028]
[Comparative Example 1] (Cream)
The same procedure as in Example 1 was conducted except that the component (B) Ultica chamadroids extract was removed in Example 1, and used in each test described above.
[0029]
[Example 2] (two-phase lotion)
In the blending amounts described below, the A component was uniformly mixed and dissolved at room temperature, and the B component was slowly stirred and added to obtain a two-phase lotion.
Figure 0003628196
[0030]
[Comparative Example 2] (Two-phase lotion)
Except for the component (B) extract of Urtica chamaedryoides in Example 2, everything was prepared in the same manner as in Example 2 and used in each test described above.
[0031]
[Test Example 2] Usability Evaluation Test The usefulness of the compositions prepared in Examples 1 and 2 and Comparative Examples 1 and 2 was tested by the following test method.
That is, 80 healthy women (25 to 40 years old) are divided into 4 groups of 20 people each, and the samples of Examples 1 and 2 and Comparative Examples 1 and 2 are applied twice a day, after the start of application. A questionnaire survey was conducted to evaluate the effect of preventing aging after 3 months (prevention of rough skin, gloss and tension of the skin). The evaluation criteria of the questionnaire are “Excellent” for valid, “Good” for slightly effective, “Yes” for slightly effective, and “No” for invalid, and compared with comparative examples. went.
As shown in Table 2 (Table 2), better results were obtained in Examples 1 and 2 than in Comparative Examples 1 and 2.
[0032]
[Table 2]
Figure 0003628196
[0033]
[Example 3] (Oil-based ointment)
Each component was mixed in the blending amounts described below, heated to 80 ° C. and gradually cooled to obtain an oily ointment.
Figure 0003628196
[0034]
[Test Example 3]
The oily ointment prepared in Example 3 was subjected to an antioxidant test according to the same method as shown in the test method for evaluating the antioxidant effect of Test Example 1. As a result, the oily ointment was superior in DPPH radical scavenging action compared to an oily ointment containing all components except that the component (B) was not blended.
[0035]
【The invention's effect】
As described above, compositions such as cosmetics, pharmaceuticals, quasi drugs, and foods containing the antioxidant of the present invention have an effect of suppressing damage caused by active oxygen and lipid peroxide generated in the living body. . Therefore, it is effective for the treatment of health and cosmetic disorders, and is also useful for the stabilization of food and drink and the improvement of storage stability.

Claims (3)

ウルティカ・カマドロイド(Urtica chamaedryoides)の抽出物を含有することを特徴とする抗酸化剤。An antioxidant characterized by containing an extract of Urtica chamaedryoides. 請求項1に記載の抗酸化剤を含有することを特徴とする組成物。A composition comprising the antioxidant according to claim 1. 請求項1に記載の抗酸化剤を含有することを特徴とする皮膚外用剤。A topical skin preparation comprising the antioxidant according to claim 1.
JP00250999A 1999-01-08 1999-01-08 Antioxidant and composition containing the same Expired - Fee Related JP3628196B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP00250999A JP3628196B2 (en) 1999-01-08 1999-01-08 Antioxidant and composition containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP00250999A JP3628196B2 (en) 1999-01-08 1999-01-08 Antioxidant and composition containing the same

Publications (2)

Publication Number Publication Date
JP2000198713A JP2000198713A (en) 2000-07-18
JP3628196B2 true JP3628196B2 (en) 2005-03-09

Family

ID=11531354

Family Applications (1)

Application Number Title Priority Date Filing Date
JP00250999A Expired - Fee Related JP3628196B2 (en) 1999-01-08 1999-01-08 Antioxidant and composition containing the same

Country Status (1)

Country Link
JP (1) JP3628196B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101441190B1 (en) * 2012-08-06 2014-09-18 제주대학교 산학협력단 Cosmetic composition containing Oreocnide fruticosa extraction

Also Published As

Publication number Publication date
JP2000198713A (en) 2000-07-18

Similar Documents

Publication Publication Date Title
KR20210095741A (en) Avocado flesh and/or skin extract rich in polyphenols and cosmetic, dermatological and nutraceutical compositions comprising same
JP4489923B2 (en) Topical skin preparation
JP3084104B2 (en) Cosmetics
JP2002370922A (en) Cosmetic containing japanese plum extract
JP2002249772A (en) Antioxidant and composition including the same
JP3809003B2 (en) Whitening agent
JP3647295B2 (en) Lipid peroxide production inhibitor and composition containing the same
JP3628196B2 (en) Antioxidant and composition containing the same
JP3597068B2 (en) Antioxidant and composition containing the same
JP3792053B2 (en) Lipid peroxide production inhibitor and composition containing the same
JP3647296B2 (en) Inhibition of tyrosinase activity and compositions containing the same
JP3597067B2 (en) Antioxidant and composition containing the same
JP3452671B2 (en) External preparation for skin
JP3224962B2 (en) External preparation for skin
JP2000198740A (en) Inhibitor of lipid peroxide production and composition containing the same
KR102602321B1 (en) Cosmetic composition for preventing or improving hair loss symptoms containing black soybean, green tangerine and turmeric extract
JP2000198980A (en) Antioxidant and composition containing same
JP2001131027A (en) Hair tonic and shampoo
JP2811479B2 (en) Hair restoration
JP4473439B2 (en) Whitening agent
JP2000290131A (en) Bleaching preparation
JP2000198715A (en) Lipid peroxide formation inhibitor and composition containing the same
JP2022102858A (en) Corneum protein carbonylation inhibitor and external skin preparation for inhibiting carbonylation of corneum protein
JP2023180676A (en) Carbonylation inhibitor
KR20230141034A (en) Cosmetic composition for preventing or improving hair loss comprising liposomes containing a mixture of black soybean, green mandarin and turmeric extract

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040825

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040907

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041018

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20041207

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20041207

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees